FDA Inspection 895455 — Lilly France S.A.S.
The FDA completed an inspection of Lilly France S.A.S. on September 16, 2014 in Fegersheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 16, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fegersheim (France)